Semaglutide (5mg/10mg/15mg)

What is Semaglutide?

Semaglutide is a peptide analogue of GLP-1, a hormone involved in glucose and appetite signaling. This page offers research vial contents of 5mg, 10mg and 15mg, not a pharmaceutical formulation.

Listed vial contents: 5mg / 10mg / 15mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.

What mechanisms are being studied?

Semaglutide activates the GLP-1 receptor. A receptor is a cellular protein that receives a chemical signal. Researchers study downstream signaling, including cyclic AMP, and how chemical modifications affect stability and albumin binding.

What are the research questions?

• GLP-1 receptor activation and cellular signaling
• Peptide stability and protein-binding comparisons
• Understanding the distinction between laboratory assays and clinical metabolic outcomes

What does the published work describe?

STEP 1 was a randomized, placebo-controlled trial in adults with overweight or obesity. It evaluated body-weight outcomes over 68 weeks using a defined clinical formulation alongside lifestyle intervention. It was not a study of this catalog reagent or an in-vitro experiment.

Experimental models in the cited papers

• STEP 1: randomized human clinical trial; adults with overweight or obesity

What could future research explore?

Further research can examine receptor responses and formulation-dependent behavior. Clinical questions about long-term metabolic outcomes require evidence from the relevant tested formulation rather than extrapolation from a vial label.

These are research directions, not established applications of the product sold here.

What are the limits of this evidence?

Clinical findings apply to the tested formulation, trial population and study conditions. They do not establish the identity, safety or effectiveness of this laboratory vial. Research Use Only: this material is not a finished medicine.

Study references

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. PMID 33567185

How should I check lot documentation?

Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. Generated sample reports illustrate the reporting flow and are not evidence of testing, purity or accreditation.